Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.980
-0.060 (-2.94%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Company Description
Cibus, Inc., an agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties.
It focuses on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or linked to environmental challenges.
Cibus, Inc. is headquartered in San Diego, California.
Cibus, Inc.
| Country | United States |
| Founded | 2010 |
| IPO Date | Jul 20, 2017 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 183 |
| CEO | Peter Beetham |
Contact Details
Address: 6455 Nancy Ridge Drive San Diego, California 92121 United States | |
| Phone | 858 450 0008 |
| Website | cibus.com |
Stock Details
| Ticker Symbol | CBUS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001705843 |
| CUSIP Number | 17166A101 |
| ISIN Number | US17166A1016 |
| Employer ID | 27-1967997 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Sean O'Connor Ph.D. | Senior Vice President and President and Chief Executive Officer of Nucelis |
| Dr. Peter Beetham B.Sc., Ph.D. | Co-Founder, Interim Chief Executive Officer, President, Chief Operating Officer and Director |
| Rory Balfour Riggs M.B.A. | Co-Founder and Chairman |
| Dr. Greg Gocal Ph.D. | Co-Founder, Chief Scientific Officer and Executive Vice President |
| Carlo Broos M.Sc. | Interim Chief Financial Officer |
| Jason Stokes J.D. | Chief Legal Officer, General Counsel and Corporate Secretary |
| Rosa Cheuk Kim J.D. | Senior Vice President of Legal |
| Dr. James Radtke Ph.D. | Senior Vice President of Product Development |
| Tony Moran | Senior Vice President of International Development |
| Noel Sauer Ph.D. | Senior Vice President of Research |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 27, 2025 | PRE 14A | Other preliminary proxy statements |
| Mar 27, 2025 | 8-K/A | [Amend] Current report |
| Mar 24, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 20, 2025 | 10-K | Annual Report |
| Mar 20, 2025 | 8-K | Current Report |
| Feb 28, 2025 | 8-K | Current Report |
| Jan 22, 2025 | 8-K | Current Report |
| Jan 21, 2025 | 424B5 | Filing |
| Dec 10, 2024 | 8-K | Current Report |
| Nov 18, 2024 | 8-K | Current Report |